Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 963230, 9 pages
http://dx.doi.org/10.1155/2014/963230
Research Article

Prevalence of Anti-Neu5Gc Antibodies in Patients with Hypothyroidism

1Department of Medical Laboratory Studies, School of Health and Medical Care, Alexander Technological Educational Institute of Thessaloniki, TEI Campus Sindos, 57400 Thessaloniki, Greece
21st Internal Medicine Department, AHEPA University General Hospital of Thessaloniki, St. Kyriakidi 1, 54636 Thessaloniki, Greece
3Aristotle University of Thessaloniki, St. Kyriakidi 1, 54636 Thessaloniki, Greece

Received 19 January 2014; Accepted 22 April 2014; Published 9 June 2014

Academic Editor: Yujiang Fang

Copyright © 2014 Phaedra Eleftheriou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Varki, “Multiple changes in sialic acid biology during human evolution,” Glycoconjugate Journal, vol. 26, no. 3, pp. 231–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Tangvoranuntakul, P. Gagneux, S. Diaz et al., “Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12045–12050, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Hirabayashi, H. Kasakura, M. Matsumoto et al., “Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers,” Japanese Journal of Cancer Research, vol. 78, no. 3, pp. 251–260, 1987. View at Google Scholar · View at Scopus
  4. H. Higashi, Y. Hirabayashi, Y. Fukui et al., “Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer,” Cancer Research, vol. 45, no. 8, pp. 3796–3802, 1985. View at Google Scholar · View at Scopus
  5. I. Miyoshi, H. Higashi, Y. Hirabayashi, S. Kato, and M. Naiki, “Detection of 4-O-acetyl-N-glycolylneuraminyl lactosylceramide as one of tumor-associated antigens in human colon cancer tissues by specific antibody,” Molecular Immunology, vol. 23, no. 6, pp. 631–638, 1986. View at Google Scholar · View at Scopus
  6. G. Marquina, H. Waki, and L. E. Fernandez, “Gangliosides expressed in human breast cancer,” Cancer Research, vol. 56, no. 22, pp. 5165–5171, 1996. View at Google Scholar
  7. P. L. Devine, B. A. Clark, G. W. Birrell et al., “The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid,” Cancer Research, vol. 51, no. 21, pp. 5826–5836, 1991. View at Google Scholar · View at Scopus
  8. S. Kawachi, T. Saida, H. Uhara, K.-I. Uemura, T. Taketomi, and K. Kano, “Heterophile Hanganutziu-Deicher antigen in ganglioside fractions of human melanoma tissues,” International Archives of Allergy and Applied Immunology, vol. 85, no. 3, pp. 381–383, 1988. View at Google Scholar · View at Scopus
  9. M. Hedlund, V. Padler-Karavani, N. M. Varki, and A. Varki, “Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 48, pp. 18936–18941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Byres, A. W. Paton, J. C. Paton et al., “Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin,” Nature, vol. 456, no. 7222, pp. 648–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Bardor, D. H. Nguyen, S. Diaz, and A. Varki, “Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells,” The Journal of Biological Chemistry, vol. 280, no. 6, pp. 4228–4237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. H. Nguyen, P. Tangvoranuntakul, and A. Varki, “Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells,” Journal of Immunology, vol. 175, no. 1, pp. 228–236, 2005. View at Google Scholar · View at Scopus
  13. V. Padler-Karavani, H. Yu, H. Cao et al., “Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease,” Glycobiology, vol. 18, no. 10, pp. 818–830, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Kostoglou-Athanassiou and K. Ntalles, “Hypothyroidism—new aspects of an old disease,” Hippokratia, vol. 14, no. 2, pp. 82–87, 2010. View at Google Scholar · View at Scopus
  15. P. Saravanan and C. M. Dayan, “Thyroid autoantibodies,” Endocrinology and Metabolism Clinics of North America, vol. 30, no. 2, pp. 315–337, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Tomer, “Genetic susceptibility to autoimmune thyroid disease: past, present, and future,” Thyroid, vol. 20, no. 7, pp. 715–725, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Iicki, C. Marcus, and F. A. Karlsson, “Hyperthyroidism and hypothyroidism in monozygotic twins: detection of stimulating and blocking THS receptor antibodies using the FRTL5-cell line,” Journal of Endocrinological Investigation, vol. 13, no. 4, pp. 327–331, 1990. View at Google Scholar · View at Scopus
  18. J.-I. Tani, K. Yoshida, H. Fukazawa et al., “Hyperthyroid Graves' disease and primary hypothyroidism caused by TSH receptor antibodies in monozygotic twins: case reports,” Endocrine Journal, vol. 45, no. 1, pp. 117–121, 1998. View at Google Scholar · View at Scopus
  19. G. Aust, K. Krohn, N. G. Morgenthaler et al., “Graves' disease and Hashimoto's thyroiditis in monozygotic twins: case study as well as transcriptomic and immunohistological analysis of thyroid tissues,” European Journal of Endocrinology, vol. 154, no. 1, pp. 13–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Cappa, C. Bizzarri, and F. Crea, “Autoimmune thyroid diseases in children,” Journal of Thyroid Research, vol. 2011, Article ID 675703, 13 pages, 2011. View at Publisher · View at Google Scholar
  21. R. G. Spiro, “The carbohydrate units of thyroglobulin,” The Journal of Biological Chemistry, vol. 240, pp. 1603–1610, 1965. View at Google Scholar · View at Scopus
  22. M. M. Liu, Q. Li, L. L. Zhao et al., “Glycosylation of recombinant human thyroid peroxidase ectodomain of insect cell origin has little effect on recognition by serum thyroid peroxidase antibody,” Chinese Medical Journal, vol. 126, no. 15, pp. 2907–2911, 2013. View at Google Scholar
  23. H. Salabè, R. Dominici, and G. B. Salabè, “Immunological properties of Tg carbohydrates: enhancement of Tg immunoreaction by removal of sialic acid,” Clinical and Experimental Immunology, vol. 25, no. 2, pp. 234–243, 1976. View at Google Scholar · View at Scopus
  24. C. R. Wynne-Roberts, “The evaluation of hydrocortisone antibodies produced in rabbits and sheep,” Immunology, vol. 26, no. 1, pp. 97–113, 1974. View at Google Scholar · View at Scopus
  25. J. Chesham and G. E. Davis, “The role of metabolism in the immunogenicity of drugs: production of antibodies to a horseradish peroxidase generated conjugate paracetamol,” Clinical and Experimental Immunology, vol. 61, no. 2, pp. 224–231, 1985. View at Google Scholar · View at Scopus
  26. M. P. Vanderpump, W. M. G. Tunbridge, J. M. French et al., “The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey,” Clinical Endocrinology, vol. 43, no. 1, pp. 55–68, 1995. View at Google Scholar · View at Scopus
  27. D. Brown and P. Rothery, Models in Biology: Mathematics, Statistics and Computing, John Wiley & Sons, New York, NY, USA, 1993.
  28. Ø. Hammer, D. A. T. Harper, and P. D. Ryan, “Past: paleontological statistics software package for education and data analysis,” Palaeontologia Electronica, vol. 4, no. 1, pp. 1–9, 2001. View at Google Scholar · View at Scopus
  29. W. J. Conover, Practical Nonparametric Statistics, John Wiley & Sons, New York, NY, USA, 3rd edition, 1999.
  30. S. S. Shapiro and M. B. Wilk, “An analysis of variance test for normality,” Biometrika, vol. 52, no. 3, pp. 591–599, 1999. View at Google Scholar
  31. C. G. Lentner, Scientific Tablesed, vol. 2, Ciba-Geigy, Basel, Switzerland, 8th edition, 1982.
  32. B. Rosner, Fundamentals of Biostatistics, Tomson Brooks/Cole, Pacific Grove, Calif, USA, 6th edition, 2006.
  33. M. P. J. Vanderpump, W. M. G. Tunbridge, J. M. French et al., “The incidence of thyroid disorders in the community:a twenty-year follow-up of the Whickham survey,” Clinical Endocrinology, vol. 43, no. 1, pp. 55–68, 1995. View at Google Scholar · View at Scopus
  34. P. Laurberg, P. I. Bülow, K. M. Pedersen, and H. Vestergaard, “Low incidence rate of overt hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake,” Thyroid, vol. 9, no. 1, pp. 33–38, 1999. View at Google Scholar · View at Scopus
  35. G. J. Canaris, N. R. Manowitz, G. Mayor, and E. C. Ridgway, “The colorado thyroid disease prevalence study,” Archives of Internal Medicine, vol. 160, no. 4, pp. 526–534, 2000. View at Google Scholar · View at Scopus
  36. A. E. Hak, H. A. P. Pols, T. J. Visser, H. A. Drexhage, A. Hofman, and J. C. Witteman, “Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study,” Annals of Internal Medicine, vol. 132, no. 4, pp. 270–278, 2000. View at Google Scholar · View at Scopus
  37. N. Amino, S. R. Hagen, N. Yamada, and S. Refetoff, “Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases,” Clinical Endocrinology, vol. 5, no. 2, pp. 115–125, 1976. View at Google Scholar · View at Scopus
  38. K. Nishimura, D. Sugiyama, Y. Kogata et al., “Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis,” Annals of Internal Medicine, vol. 146, no. 11, pp. 797–808, 2007. View at Google Scholar · View at Scopus
  39. O. M. R. Westwood, P. N. Nelson, and F. C. Hay, “Rheumatoid factors: what's new?” Rheumatology, vol. 45, no. 4, pp. 379–385, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Nishimura, D. Sugiyama, Y. Kogata et al., “Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis,” Annals of Internal Medicine, vol. 146, no. 11, pp. 797–808, 2007. View at Google Scholar · View at Scopus
  41. C. S. William, P.S. David, and H. F. Barton, Rheumatoid Arthritis, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2004.
  42. J. Guo, S. M. McLachlan, S. Hutchison, and B. Rapoport, “The greater glycan content of recombinant human thyroid peroxidase of mammalian than of insect cell origin facilitates purification to homogeneity of enzymatically protein remaining soluble at high concentration,” Endocrinology, vol. 139, no. 3, pp. 999–1005, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Ming-ming, L. Qing, Z. Lan-lan et al., “Glycosylation of recombinant human thyroid peroxidase ectodomain of insect cell origin has little effect on recognition by serum thyroid peroxidase antibody,” Chinese Medical Journal, vol. 126, no. 15, pp. 2907–2911, 2013. View at Google Scholar
  44. K. Yamamoto, T. Tsuji, O. Tarutani, and T. Osawa, “Structural changes of carbohydrate chains of human thyroglobulin accompanying malignant transformations of thyroid glands,” European Journal of Biochemistry, vol. 143, no. 1, pp. 133–144, 1984. View at Google Scholar · View at Scopus
  45. J. F. G. Vliegenthart, P. de Waard, A. Koorevaar, and J. P. Kamerling, “Structure determination of 1H NMR spectroscopy of (sulfated) sialylated N-linked carbohydrate chains released from porcine thyroglobulin by peptide-N4-(N-acetyl-β-glucosaminyl)asparagine amidase-F,” The Journal of Biological Chemistry, vol. 266, no. 7, pp. 4237–4243, 1991. View at Google Scholar · View at Scopus
  46. A. Iicki, C. Marcus, and F. A. Karlsson, “Hyperthyroidism and hypothyroidism in monozygotic twins: detection of stimulating and blocking THS receptor antibodies using the FRTL5-cell line,” Journal of Endocrinological Investigation, vol. 13, no. 4, pp. 327–331, 1990. View at Google Scholar · View at Scopus
  47. Y. Tomer, “Genetic susceptibility to autoimmune thyroid disease: past, present, and future,” Thyroid, vol. 20, no. 7, pp. 715–725, 2010. View at Google Scholar · View at Scopus
  48. A. Varki, “Sialic acids in human health and disease,” Trends in Molecular Medicine, vol. 14, no. 8, pp. 351–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Savilahti, M. Viander, M. Perkkio, E. Vainio, K. Kalimo, and T. Reunala, “IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease,” The Lancet, vol. 1, no. 8320, pp. 320–322, 1983. View at Google Scholar · View at Scopus
  50. N. Lycke, A. Kilander, L.-A. Nilsson, A. Tarkowski, and N. Werner, “Production of antibodies to gliadin in intestinal mucosa of patients with coeliac disease: a study at the single cell level,” Gut, vol. 30, no. 1, pp. 72–77, 1989. View at Google Scholar · View at Scopus